Research Topics
Species | S K GargSummaryAffiliation: University of Colorado Denver Country: USA Publications
| Collaborators
|
Detail Information
Publications
Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trialSatish K Garg
Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Center Aurora, Colorado Diabetes Technology and Therapeutics University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
Endocr Pract 19:19-28. 2013....- Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE studySatish Garg
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, USA
Diabetes Technol Ther 14:205-9. 2012..The efficacy of automatic suspension of insulin delivery in induced hypoglycemia among subjects with type 1 diabetes was evaluated... - Preference for a new prefilled insulin pen compared with the original penS Garg
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO 80045, USA
Curr Med Res Opin 27:2323-33. 2011..The prevalence of diabetes is increasing in the United States and worldwide. Insulin injection pens are preferred over vial/syringe methods, and are designed to facilitate use, improve adherence, and provide accurate insulin delivery... 
Clinical experience with insulin glargine in type 1 diabetesSatish Garg
Barbara Davis Campus for Childhood Diabetes, University of Colorado Denver, 1775 Aurora Court, Aurora, CO 80045, USA
Diabetes Technol Ther 12:835-46. 2010..However, these same trials show a significantly lower risk for hypoglycemia with insulin glargine compared with NPH insulin in adults...- Effects of colesevelam on LDL-C, A1c and GLP-1 levels in patients with type 1 diabetes: a pilot randomized double-blind trialS K Garg
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
Diabetes Obes Metab 13:137-43. 2011..colesevelam is indicated to lower low density lipoprotein cholesterol (LDL-C) in hyperlipidaemia and improve glycaemic control in adults with type 2 diabetes. This short-term pilot study evaluates its effects in type 1 diabetes... - The role of basal insulin and glucagon-like peptide-1 agonists in the therapeutic management of type 2 diabetes--a comprehensive reviewSatish K Garg
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado 80045, USA
Diabetes Technol Ther 12:11-24. 2010..Further comparative data are needed to fully investigate the relative positioning of these therapies within the T2DM treatment paradigm... - Self-monitoring of blood glucoseS K Garg
University of Colorado Health Science Center, Aurora, CO, USA
Int J Clin Pract Suppl . 2011..Although SMBG is not 'new' technology, much research needs to be completed before we fully understand this tool's full impact, particularly as CGM becomes more popular... - Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trialSatish K Garg
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, USA
Diabetes Technol Ther 11:S5-S16. 2009..AIR((R)) inhaled insulin (system from Eli Lilly and Company, Indianapolis, IN) (AIR is a registered trademark of Alkermes, Inc., Cambridge, MA) may be an efficacious and safe alternative to subcutaneously injected (SC) mealtime insulin... - Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitusSatish Garg
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, Colorado 80045, USA
Endocr Pract 16:486-505. 2010..To compare rapid-acting insulin analogues with regular human insulin in terms of hemoglobin A1c, hypoglycemia, and insulin dose when used in a basal-bolus regimen in patients with type 1 diabetes mellitus... - Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systemsSatish K Garg
Barbara Davis Center for Childhood Diabetes, School of Medicine, University of Colorado at Denver, Aurora, Colorado 80045, USA
Diabetes Technol Ther 11:65-72. 2009.... - Time lag characterization of two continuous glucose monitoring systemsSatish K Garg
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, School of Medicine, Aurora, CO 80045, United States
Diabetes Res Clin Pract 87:348-53. 2010.... - Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month studySatish K Garg
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, School of Medicine, Aurora, Colorado, USA
Diabetes Care 34:574-9. 2011..To compare use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injection (MDI) therapy versus continuous subcutaneous insulin infusion (CSII) therapy for 6 months... 
Long-term efficacy of humalog in subjects with Type 1 diabetes mellitusS K Garg
Barbara Davis Center for Childhood Diabetes, Department of Paediatrics, University of Colorado Health Sciences Center, Denver, USA
Diabet Med 16:384-7. 1999..To evaluate the long-term effectiveness of Humalog insulin in lowering post meal glucose excursions...- The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetesH P Chase
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
Diabetes Care 24:430-4. 2001.... - Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trialS L Ellis
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO 80045, USA
Diabet Med 28:1176-81. 2011..This study evaluates the clinical implications of sitagliptin in adult patients with Type 1 diabetes... - Review of phase 2 studies utilizing the AIR particle technology in the delivery of human insulin inhalation powder versus subcutaneous regular or lispro insulin in subjects with type 1 or type 2 diabetesSamuel L Ellis
Barbara Davis Center for Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado 80045, USA
Diabetes Technol Ther 9:S48-56. 2007..Phase 3 studies are ongoing to further evaluate safety and efficacy of HIIP... - Use of continuous glucose monitoring in patients with type 1 diabetesSamuel L Ellis
Barbara Davis Center for Diabetes, University of Colorado Denver, A140, P O Box 6511 Aurora, CO 80045, USA
Curr Diabetes Rev 4:207-17. 2008..In addition, for better clinical care and usage, algorithms also need to be developed for both patients and the providers to guide them for their ongoing diabetes care... - Optimized Basal-bolus insulin regimens in type 1 diabetes: insulin glulisine versus regular human insulin in combination with Basal insulin glargineSatish K Garg
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
Endocr Pract 11:11-7. 2005..03). CONCLUSION: Better A1c reductions were obtained with premeal GLU, but postmeal administration of GLU was as safe and effective as premeal GLU or RHI in combination with insulin glargine and was not associated with weight gain... - Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance softwareSatish K Garg
Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado 80045, USA
Diabetes Technol Ther 10:369-75. 2008..Management of type 1 diabetes could be significantly improved with the availability of computerized insulin algorithms for home use... - Continuous subcutaneous glucose monitoring in children with type 1 diabetesH P Chase
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, Denver, Colorado 80262, USA
Pediatrics 107:222-6. 2001.... - Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetesS K Garg
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver 80262, USA
Diabetes Care 22:1708-14. 1999..Redwood City, CA) with capillary blood glucose values that were determined 1) in a controlled outpatient clinic setting and 2) in a home setting... - Reduced severe hypoglycemia with insulin glargine in intensively treated adults with type 1 diabetesSatish K Garg
Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
Diabetes Technol Ther 6:589-95. 2004..The goal of new therapies introduced for type 1 diabetes should be to decrease hypoglycemic episodes while improving glycemic control... - Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetesSatish K Garg
Department of Medicine and Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
Diabetes Care 27:734-8. 2004..The capability of emerging glucose sensor technology to continuously monitor glucose levels may provide ways to achieve glycemic targets while reducing hypoglycemia... - Glycemic parameters with multiple daily injections using insulin glargine versus insulin pumpSatish K Garg
Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
Diabetes Technol Ther 6:9-15. 2004..However, costs and episodes of diabetic ketoacidosis are significantly higher for insulin pump users... - Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulinH Peter Chase
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver, Colorado, USA
J Pediatr 143:737-40. 2003..The numbers of nonsevere and severe hypoglycemic events, hemoglobin A1c values, body weight, and daily insulin dose were recorded at each clinic visit... - Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomesSatish K Garg
Department of Medicine, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA
Endocr Pract 9:187-93. 2003..A prospective, randomized study with adequate sample size needs to be performed in order to confirm these conclusions... - Use of the GlucoWatch biographer in children with type 1 diabetesH Peter Chase
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA
Pediatrics 111:790-4. 2003..The use of the biographer with an alarm to detect nocturnal hypoglycemia has the potential to increase the safety of diabetes management in children... - Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetesSatish K Garg
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, Colorado, USA
Diabetes Care 30:3023-5. 2007 - Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisineHeather Ulrich
Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Denver, CO 80232, USA
Vasc Health Risk Manag 3:245-54. 2007..In summary, insulin glulisine is a safe, effective, and well tolerated rapid-acting insulin analogue across all BMIs and a worthy option for prandial glucose control in type 1 or 2 DM... - Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargineSatish K Garg
Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA
Diabetes Res Clin Pract 66:49-56. 2004..Sixty-three subjects were taking glargine in the morning, 125 were taking glargine in the evening, and 104 were splitting the glargine dose between the morning and evening... - Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetesH P Chase
Department of Paediatrics, Barbara Davis Center, University of Colorado Health Sciences Center, Denver, CO 80262, USA
Diabet Med 19:317-21. 2002..To determine if one method of short-acting insulin bolus administration is superior to other methods in managing a meal high in carbohydrates, calories and fat... - Feasibility of 10-day use of a continuous glucose-monitoring system in adults with type 1 diabetesSatish K Garg
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, USA
Diabetes Care 32:436-8. 2009..The purpose of this pilot study was to evaluate the feasibility of 10-day use of a transcutaneous, real-time, continuous glucose-monitoring (CGM) system. All previous reports using different CGM systems were for 3-, 5-, or 7-day use... - Health impact from frequent and continuous glucose monitoringSatish K Garg
Department of Medicine and Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
Diabetes Technol Ther 6:523-4. 2004 - Use of insulin glargine in children under age 6 with type 1 diabetesBrenner Dixon
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO, USA
Pediatr Diabetes 6:150-4. 2005..CONCLUSIONS: SH was decreased, particularly at night (from 12 episodes to one), after the introduction of glargine in young children with T1D... - The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetesA Kretowski
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Mail Stop A140, P O Box 6511, Aurora, CO 80045 6511, USA
Diabetologia 49:1946-54. 2006..The aim of the present study was to evaluate the association of apolipoprotein A-IV (APOA4) polymorphisms with coronary artery calcification (CAC) progression, a marker of subclinical atherosclerosis... - Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetesSatish K Garg
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 E 9th Ave B140, Denver, CO 80262, USA
Expert Opin Pharmacother 6:643-51. 2005..In conclusion, insulin glulisine is an effective, safe and well-tolerated rapid-acting insulin analogue... - 24-h ambulatory blood pressure monitoring in healthy young adult Anglo, Hispanic, and African-American subjectsH P Chase
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
Am J Hypertens 10:18-23. 1997..It also shows that higher blood pressures are present among males and among subjects of African-American descent in the teenage and young adult population... - Use of continuous glucose monitoring to improve diabetes mellitus managementSamuel L Ellis
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, Colorado, USA
Endocrinol Metab Clin North Am 36:46-68. 2007 - The role of continuous glucose sensors in diabetes careSatish K Garg
Department of Medicine, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Campus Box B-140, Denver, CO 80262, USA
Endocrinol Metab Clin North Am 33:163-73, x-xi. 2004 - Optimizing insulin therapy in pregnant women with type 1 diabetes mellitusPeter A Gottlieb
Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
Treat Endocrinol 1:235-40. 2002..No studies of insulin aspart in pregnancy have been published in full. In addition to optimization of glycemic control, frequent assessment for development and/or progression of microvascular complications is necessary during pregnancy... - Modem transmission of glucose values reduces the costs and need for clinic visitsH Peter Chase
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
Diabetes Care 26:1475-9. 2003..To determine whether modem technology allows for effective management of type 1 diabetes when used in lieu of a clinic visit... - New insulin analoguesSatish K Garg
University of Colorado, Denver, Colorado, USA
Diabetes Technol Ther 7:813-7. 2005 - The clinical performance and ease of use of a blood glucose meter that uses a 10-test diskSatish K Garg
Department of Medicine and Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA
Diabetes Technol Ther 6:495-502. 2004..Subjects found the meter easy and intuitive to learn to use. The study subjects were able to correctly use the meter after independently reviewing the user guide... - Inflammatory markers and diabetic retinopathy in type 1 diabetesKenneth E Izuora
Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Ave, Box B-140, Denver, CO, USA
Diabetes Care 28:714-5. 2005 - Awareness and treatment of dyslipidemia in young adults with type 1 diabetesR Paul Wadwa
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Ave, Box B140, Denver, CO 80262, USA
Diabetes Care 28:1051-6. 2005..In this report, we describe the prevalence of dyslipidemia and adequacy of pharmacological treatment in patients with type 1 diabetes and comparable nondiabetic subjects...